Mental Health Blogs

After many attempts and many years, Lilly has gotten the FDA to approve Relprevv, its long-acting Zyprexa injectable, for he treatment of schizophrenia. God help any patient who ends up on it.

Go to Source

Related posts:

1. Utah Settles Zyprexa Claims For $24 Million
2. Zyprexa Gets FDA Approval For Use In Adolescents
3. Lilly, New Mexico Settle Zyprexa Case For $15.5 Million
4. Lilly May Settle Zyprexa Claims With More States
5. New Zyprexa Documents Show Lilly Ghostwrote Zyprexa Studies